Facebook Icon Print Created with Sketch. Twitter Icon Created with Sketch. Created with Sketch. LinkedIn Icon Green Check Icon Created with Sketch. YouTube Icon Right Arrow Icon Mobile Menu Icon Chevron Right Icon Phone Icon Health Study Area: AutoImmune Disease Health Study Area: AutoImmune Disease Health Study Area: Blood Cancer Health Study Area: Blood Cancer Health Study Area: Cardiovascular Disease Health Study Area: Cardiovascular Disease Health Study Area: Fibrosis Health Study Area: Fibrosis Health Study Area: Gastrointestinal Cancer Health Study Area: Gastrointestinal Cancer Health Study Area: Genitourinary Health Study Area: Genitourinary Health Study Area: Head and Neck Cancer Health Study Area: Head and Neck Cancer Health Study Area: Lung Cancer Health Study Area: Lung Cancer Health Study Area: Melanoma Health Study Area: Melanoma Health Study Area: Women's Cancer Health Study Area: Breast Cancer Health Study Area: Breast Cancer For Caregivers For Caregivers For Clinicians Communities FAQs For Parents For Parents For Patients For Patients Chevron Icon Bookmark Icon Map Icon Share Icon Direction Arrow Icon Direction Arrow Icon Page Icon Location Icon Search Icon External Link Icon Help Icon Help Icon Error Icon Glossary Email Icon Gender Both Gender Both Gender Male Gender Female Created with Sketch. Created with Sketch. Health Study Area: NASH Instagram Created with sketchtool. For Clinicians

Please Log In/Join Now first, and then use this function!

COVID-19 (Coronavirus) Message for Patients

Note: As a result of the current COVID-19 (Coronavirus) restrictions, research sites may incorrectly be listed as recruiting or be delayed in responding to patient inquiries due to possible closures. It is suggested that interested patients awaiting a response or current study patients can contact the research site at the phone number provided to ask about study status or confirm scheduled appointments before arriving. Read more about BMS's response to COVID-19 at www.BMS.com.



Researching NASH

As you may already know, nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD) – the most common chronic liver disease in the world. NASH is a serious disease that can progress to chronic liver damage such as advanced fibrosis or cirrhosis, liver failure, or liver cancer. Right now, clinical research for NASH is underway, and you may be eligible to participate.

 

Jump to Studies

NASH Clinical Trials

NASH Clinical Trials

.

Available Clinical Trials

Thank you for considering a clinical trial

Below you will find clinical trials that are either currently recruiting participants (noted as "Recruiting") or starting to recruit participants (noted as "Not Yet Recruiting").

Here are some options for you to find more information:

  1. Browse the trials available on your own and click on "View Trial Details" for more information, along with locations that are recruiting participants.
    - or -
  2. Let us help you find a trial: Pre-Screen Now and answer a few questions to determine if there is a trial that might be right for you. 



Explore NASH Resources

A NASH diagnosis is characterized by NAFLD with steatosis (retaining excess fatty tissue), liver cell injury, liver cell death, and inflammation. Other symptoms include:

  • Loss of appetite
  • Swelling in the legs
  • Confusion
  • Slurred speech
  • Jaundice
  • Abdominal discomfort

In most cases, NASH is the consequence of a diet high in fat and sugar, and a lack of physical activity. With lifestyle changes – like healthier eating and exercise – the liver can actually begin to repair itself. But if you’ve recently been diagnosed with NASH, it can be hard to know what steps to take.

For additional information and support regarding NASH, please visit one of the following advocacy sites:

Bristol Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol Myers Squibb are meant for informational purposes only and are not meant to replace a physician’s medical advice or imply endorsement.

About Clinical Trials

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -
Call 855-907-3286 or email clinical.trials@bms.com